Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.
Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, Young J, Bucher HC, Babiker AG; CASCADE Collaboration in EuroCoord. Stirrup OT, et al. HIV Med. 2018 Mar;19(3):184-194. doi: 10.1111/hiv.12567. Epub 2017 Dec 1. HIV Med. 2018. PMID: 29230953 Free PMC article. Clinical Trial.
Impact of treatment changes on the interpretation of the Concorde trial.
White IR, Walker S, Babiker AG, Darbyshire JH. White IR, et al. AIDS. 1997 Jul;11(8):999-1006. doi: 10.1097/00002030-199708000-00008. AIDS. 1997. PMID: 9223734 Clinical Trial.
Age as a determinant of survival in HIV infection.
Babiker AG, Peto T, Porter K, Walker AS, Darbyshire JH. Babiker AG, et al. J Clin Epidemiol. 2001 Dec;54 Suppl 1:S16-21. doi: 10.1016/s0895-4356(01)00456-5. J Clin Epidemiol. 2001. PMID: 11750205
Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?
Easterbrook PJ, Goodall RL, Babiker AG, Yu LM, Smith D, Cooper DA, Gazzard BG. Easterbrook PJ, et al. J Antimicrob Chemother. 1999 Mar;43(3):379-88. doi: 10.1093/jac/43.3.379. J Antimicrob Chemother. 1999. PMID: 10223594 Clinical Trial.
91 results
Jump to page
Feedback